These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 16762377

  • 1. Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade.
    Takada-Takatori Y, Kume T, Sugimoto M, Katsuki H, Sugimoto H, Akaike A.
    Neuropharmacology; 2006 Sep; 51(3):474-86. PubMed ID: 16762377
    [Abstract] [Full Text] [Related]

  • 2. Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons.
    Takada Y, Yonezawa A, Kume T, Katsuki H, Kaneko S, Sugimoto H, Akaike A.
    J Pharmacol Exp Ther; 2003 Aug; 306(2):772-7. PubMed ID: 12734391
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil.
    Takada-Takatori Y, Kume T, Ohgi Y, Izumi Y, Niidome T, Fujii T, Sugimoto H, Akaike A.
    J Neurosci Res; 2008 Dec; 86(16):3575-83. PubMed ID: 18655200
    [Abstract] [Full Text] [Related]

  • 4. Neuroprotective effects of galanthamine and tacrine against glutamate neurotoxicity.
    Takada-Takatori Y, Kume T, Sugimoto M, Katsuki H, Niidome T, Sugimoto H, Fujii T, Okabe S, Akaike A.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):19-26. PubMed ID: 16996497
    [Abstract] [Full Text] [Related]

  • 5. Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons.
    Kume T, Sugimoto M, Takada Y, Yamaguchi T, Yonezawa A, Katsuki H, Sugimoto H, Akaike A.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):77-85. PubMed ID: 16313899
    [Abstract] [Full Text] [Related]

  • 6. [Mechanisms of neuroprotective effects of therapeutic acetylcholinesterase inhibitors used in treatment of Alzheimer's disease].
    Takatori Y.
    Yakugaku Zasshi; 2006 Aug 19; 126(8):607-16. PubMed ID: 16880719
    [Abstract] [Full Text] [Related]

  • 7. α7 Nicotinic receptor activation reduces β-amyloid-induced apoptosis by inhibiting caspase-independent death through phosphatidylinositol 3-kinase signaling.
    Yu W, Mechawar N, Krantic S, Quirion R.
    J Neurochem; 2011 Nov 19; 119(4):848-58. PubMed ID: 21884524
    [Abstract] [Full Text] [Related]

  • 8. 5-Iodo-A-85380, a specific ligand for alpha 4 beta 2 nicotinic acetylcholine receptors, prevents glutamate neurotoxicity in rat cortical cultured neurons.
    Ueda M, Iida Y, Kitamura Y, Kawashima H, Ogawa M, Magata Y, Saji H.
    Brain Res; 2008 Mar 14; 1199():46-52. PubMed ID: 18269932
    [Abstract] [Full Text] [Related]

  • 9. Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity.
    Kihara T, Sawada H, Nakamizo T, Kanki R, Yamashita H, Maelicke A, Shimohama S.
    Biochem Biophys Res Commun; 2004 Dec 17; 325(3):976-82. PubMed ID: 15541385
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection.
    Akaike A, Takada-Takatori Y, Kume T, Izumi Y.
    J Mol Neurosci; 2010 Jan 17; 40(1-2):211-6. PubMed ID: 19714494
    [Abstract] [Full Text] [Related]

  • 11. Bis(7)-tacrine attenuates beta amyloid-induced neuronal apoptosis by regulating L-type calcium channels.
    Fu H, Li W, Lao Y, Luo J, Lee NT, Kan KK, Tsang HW, Tsim KW, Pang Y, Li Z, Chang DC, Li M, Han Y.
    J Neurochem; 2006 Sep 17; 98(5):1400-10. PubMed ID: 16771827
    [Abstract] [Full Text] [Related]

  • 12. Cholinergic protection via alpha7 nicotinic acetylcholine receptors and PI3K-Akt pathway in LPS-induced neuroinflammation.
    Tyagi E, Agrawal R, Nath C, Shukla R.
    Neurochem Int; 2010 Jan 17; 56(1):135-42. PubMed ID: 19781587
    [Abstract] [Full Text] [Related]

  • 13. Study of neuroprotection of donepezil, a therapy for Alzheimer's disease.
    Akasofu S, Kimura M, Kosasa T, Sawada K, Ogura H.
    Chem Biol Interact; 2008 Sep 25; 175(1-3):222-6. PubMed ID: 18571635
    [Abstract] [Full Text] [Related]

  • 14. New insight into the functional role of acetylcholine in developing embryonic rat retinal neurons.
    Yasuyoshi H, Kashii S, Kikuchi M, Zhang S, Honda Y, Akaike A.
    Invest Ophthalmol Vis Sci; 2002 Feb 25; 43(2):446-51. PubMed ID: 11818389
    [Abstract] [Full Text] [Related]

  • 15. Nicotine-induced phosphorylation of ERK in mouse primary cortical neurons: evidence for involvement of glutamatergic signaling and CaMKII.
    Steiner RC, Heath CJ, Picciotto MR.
    J Neurochem; 2007 Oct 25; 103(2):666-78. PubMed ID: 17666046
    [Abstract] [Full Text] [Related]

  • 16. Preclinical evidence of neuroprotection by cholinesterase inhibitors.
    Akaike A.
    Alzheimer Dis Assoc Disord; 2006 Oct 25; 20(2 Suppl 1):S8-11. PubMed ID: 16772755
    [Abstract] [Full Text] [Related]

  • 17. Mecamylamine prevents neuronal apoptosis induced by glutamate and low potassium via differential anticholinergic-independent mechanisms.
    Fu H, Dou J, Li W, Luo J, Li KC, Lam CS, Lee NT, Li M, Han Y.
    Neuropharmacology; 2008 Mar 25; 54(4):755-65. PubMed ID: 18222492
    [Abstract] [Full Text] [Related]

  • 18. Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta-induced neuronal cell death.
    Noh MY, Koh SH, Kim Y, Kim HY, Cho GW, Kim SH.
    J Neurochem; 2009 Mar 25; 108(5):1116-25. PubMed ID: 19077054
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade.
    Kihara T, Shimohama S, Sawada H, Honda K, Nakamizo T, Kanki R, Yamashita H, Akaike A.
    J Neurosci Res; 2002 Nov 01; 70(3):274-82. PubMed ID: 12391586
    [Abstract] [Full Text] [Related]

  • 20. Acetylcholine neuroprotection against glutamate-induced excitotoxicity in adult pig retinal ganglion cells is partially mediated through alpha4 nAChRs.
    Thompson SA, Smith O, Linn DM, Linn CL.
    Exp Eye Res; 2006 Nov 01; 83(5):1135-45. PubMed ID: 16928373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.